Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation
Standard
Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation. / Reichart, Daniel; Schofer, Niklas; Deuschl, Florian; Schaefer, Andreas; Blankenberg, Stefan; Reichenspurner, Hermann; Schaefer, Ulrich; Conradi, Lenard.
in: THORAC CARD SURG REP, Jahrgang 6, Nr. 1, 01.2017, S. e29-e31.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Transcatheter Tricuspid Valve-In-Ring and Aortic Valve-In-Valve Implantation
AU - Reichart, Daniel
AU - Schofer, Niklas
AU - Deuschl, Florian
AU - Schaefer, Andreas
AU - Blankenberg, Stefan
AU - Reichenspurner, Hermann
AU - Schaefer, Ulrich
AU - Conradi, Lenard
PY - 2017/1
Y1 - 2017/1
N2 - Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce. Case Description Here, we report a case of successful concomitant transcatheter aortic valve-in-valve (ViV) and tricuspid valve-in-ring (ViR) procedures using a 23-mm CoreValve Evolut R THV (Medtronic, Inc., Minneapolis, Minnesota, United States) in aortic position and a 29-mm SAPIEN3 (Edwards Lifesciences, Inc., Irvine, California, United States) THV in tricuspid position. Conclusion This case demonstrates feasibility of concomitant transcatheter aortic ViV and tricuspid ViR procedures.
AB - Background Transcatheter heart valve (THV) therapies have shown to be an alternative to surgical valve replacement, especially in high-risk patients requiring redo surgery. However, reports of transcatheter-based interventions in tricuspid valve position are scarce. Case Description Here, we report a case of successful concomitant transcatheter aortic valve-in-valve (ViV) and tricuspid valve-in-ring (ViR) procedures using a 23-mm CoreValve Evolut R THV (Medtronic, Inc., Minneapolis, Minnesota, United States) in aortic position and a 29-mm SAPIEN3 (Edwards Lifesciences, Inc., Irvine, California, United States) THV in tricuspid position. Conclusion This case demonstrates feasibility of concomitant transcatheter aortic ViV and tricuspid ViR procedures.
U2 - 10.1055/s-0037-1606345
DO - 10.1055/s-0037-1606345
M3 - SCORING: Journal article
C2 - 28929044
VL - 6
SP - e29-e31
JO - THORAC CARD SURG REP
JF - THORAC CARD SURG REP
SN - 2194-7635
IS - 1
ER -